Yonghe Medical Group Co., Ltd. (HKG:2279)
2.130
-0.060 (-2.74%)
Last updated: Jul 15, 2025
Yonghe Medical Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -226.34 | -546.39 | -85.86 | 120.19 | 163.33 | Upgrade |
Depreciation & Amortization | 312.75 | 333.57 | 220.22 | 199.8 | 158.72 | Upgrade |
Other Amortization | 2.46 | 1.27 | 4.46 | 1.17 | 0.4 | Upgrade |
Loss (Gain) From Sale of Assets | 42.23 | 45.9 | -0.09 | 1.13 | 3.98 | Upgrade |
Asset Writedown & Restructuring Costs | 60.83 | 28.13 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.32 | 0.26 | 0.14 | -0.15 | 0.36 | Upgrade |
Stock-Based Compensation | 0.11 | 0.18 | 0.18 | 0.18 | 3.61 | Upgrade |
Other Operating Activities | 7.76 | 19.87 | -122.71 | 38.12 | 67.02 | Upgrade |
Change in Accounts Receivable | 35.32 | 0.15 | -1.94 | -8.21 | -45.84 | Upgrade |
Change in Inventory | 35.47 | 12.08 | -34.95 | -26.12 | -12.51 | Upgrade |
Change in Accounts Payable | -44.2 | 60.46 | -53.47 | 42.3 | 65.42 | Upgrade |
Change in Unearned Revenue | 7.7 | 27.38 | -34.55 | 68.88 | 97.07 | Upgrade |
Change in Other Net Operating Assets | -5.15 | - | - | - | - | Upgrade |
Operating Cash Flow | 228.62 | -17.15 | -108.56 | 437.28 | 501.57 | Upgrade |
Operating Cash Flow Growth | - | - | - | -12.82% | 174.86% | Upgrade |
Capital Expenditures | -45.66 | -159.19 | -240.57 | -181.63 | -142.2 | Upgrade |
Sale of Property, Plant & Equipment | 0.87 | 3.03 | 1.79 | 0.5 | 0.18 | Upgrade |
Cash Acquisitions | -0.37 | -1.6 | - | -3.8 | - | Upgrade |
Divestitures | - | 7.5 | - | - | 0.15 | Upgrade |
Sale (Purchase) of Intangibles | -8.1 | -12.12 | -2.94 | -9.01 | -0.64 | Upgrade |
Investment in Securities | - | 398.25 | -408.84 | - | 0.13 | Upgrade |
Other Investing Activities | - | 9.71 | - | - | - | Upgrade |
Investing Cash Flow | -53.26 | 245.58 | -650.57 | -193.94 | -142.39 | Upgrade |
Short-Term Debt Issued | 79.81 | 154.54 | 75.47 | 232.69 | 28.87 | Upgrade |
Total Debt Issued | 79.81 | 154.54 | 75.47 | 232.69 | 28.87 | Upgrade |
Short-Term Debt Repaid | -182.55 | -1.8 | -149.64 | -184.85 | -47.83 | Upgrade |
Long-Term Debt Repaid | -182.2 | -239.1 | -194.66 | -204.74 | -132.29 | Upgrade |
Total Debt Repaid | -364.75 | -240.9 | -344.3 | -389.6 | -180.12 | Upgrade |
Net Debt Issued (Repaid) | -284.94 | -86.37 | -268.84 | -156.91 | -151.25 | Upgrade |
Issuance of Common Stock | - | - | 91.88 | 1,381 | - | Upgrade |
Repurchase of Common Stock | -1.94 | -96.5 | -79.04 | - | - | Upgrade |
Common Dividends Paid | - | - | -43.16 | -69.8 | - | Upgrade |
Other Financing Activities | -3.84 | -2.34 | -33.89 | -125.8 | -4.87 | Upgrade |
Financing Cash Flow | -290.72 | -185.2 | -333.05 | 1,028 | -156.12 | Upgrade |
Foreign Exchange Rate Adjustments | -0.01 | -5.1 | 91.08 | 1.78 | - | Upgrade |
Net Cash Flow | -115.37 | 38.12 | -1,001 | 1,273 | 203.07 | Upgrade |
Free Cash Flow | 182.95 | -176.35 | -349.14 | 255.65 | 359.37 | Upgrade |
Free Cash Flow Growth | - | - | - | -28.86% | 368.71% | Upgrade |
Free Cash Flow Margin | 10.14% | -9.92% | -24.71% | 11.79% | 21.93% | Upgrade |
Free Cash Flow Per Share | 0.36 | -0.35 | -0.68 | 0.59 | 0.86 | Upgrade |
Cash Interest Paid | 3.84 | 2.34 | 1.61 | 3.95 | 1.49 | Upgrade |
Cash Income Tax Paid | 4.47 | 5.5 | 58.11 | 103.92 | 40.67 | Upgrade |
Levered Free Cash Flow | 151.87 | -53.08 | -314.18 | 226.97 | 318.98 | Upgrade |
Unlevered Free Cash Flow | 177.63 | -19.23 | -282.16 | 259.43 | 341.66 | Upgrade |
Change in Net Working Capital | 7.71 | -102.98 | 162.59 | -92.36 | -152.6 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.